Business Wire

Business Wire is the global leader in news release distribution and regulatory disclosure. Business Wire delivers news and multimedia directly into editorial systems and leading online news platforms and is a trusted source for news organisations, journalists, investment professionals and regulatory authorities.
Results: 6613-6624 of 19887

Phase 3 Data for Incyte’s Retifanlimab (Zynyz®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet

Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera








